G435-0920 Screening compound: 1-{1-[2-(4-butoxyphenyl)pyrazolo[1,5-a]pyrazin-4-yl]piperidine-4-carbonyl}-4-(pyridin-2-yl)piperazine

G435-0920 Screening compound: 1-{1-[2-(4-butoxyphenyl)pyrazolo[1,5-a]pyrazin-4-yl]piperidine-4-carbonyl}-4-(pyridin-2-yl)piperazine
G435-0920 Screening compound: 1-{1-[2-(4-butoxyphenyl)pyrazolo[1,5-a]pyrazin-4-yl]piperidine-4-carbonyl}-4-(pyridin-2-yl)piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound G435-0920
1-{1-[2-(4-butoxyphenyl)pyrazolo[1,5-a]pyrazin-4-yl]piperidine-4-carbonyl}-4-(pyridin-2-yl)piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G435-0920

Molecular Formula

C31H37N7O2 (C31 H37 N7 O2)

Compound Name

1-{1-[2-(4-butoxyphenyl)pyrazolo[1,5-a]pyrazin-4-yl]piperidine-4-carbonyl}-4-(pyridin-2-yl)piperazine

IUPAC name

1-{1-[2-(4-butoxyphenyl)pyrazolo[15-a]pyrazin-4-yl]piperidine-4-carbonyl}-4-(pyridin-2-yl)piperazine

SMILES

CCCCOc(cc1)ccc1-c1nn(ccnc2N(CC3)CCC3C(N(CC3)CCN3c3ncccc3)=O)c2c1

InChI

InChI=1S/C31H37N7O2/c1-2-3-22-40-26-9-7-24(8-10-26)27-23-28-30(33-14-17-38(28)34-27)36-15-11-25(12-16-36)31(39)37-20-18-35(19-21-37)29-6-4-5-13-32-29/h4-10,13-14,17,23,25H,2-3,11-12,15-16,18-22H2,1H3

InChI Key

ADXFRJDVNLAAJR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15014224

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

539.68

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

5.394

Distribution Coefficient, logD

5.386

Water Solubility, LogSw

-5.25

Polar Surface Area

59.112

Acid Dissociation Constant (pKa)

21.73

Base Dissociation Constant (pKb)

5.71

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

41.90

G435-0920 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Epigenetics Focused Set (26518 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with G435-0920 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G435-0920?
Check Price and Availability of G435-0920, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G435-0920 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G435-0920
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G435-0920
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G435-0920 available by request